
Board-Certified · Internal Medicine · Medical Director
All 50 states + DC·Video visit
In-network: Aetna, BCBS, UnitedHealthcare +18 more plans
As branded Ozempic and Wegovy came off the FDA shortage list, most compounded semaglutide is no longer permitted. A provider can review your options — branded GLP-1, tirzepatide, or alternatives — online.
Also called: compounded GLP-1 · semaglutide from compounding pharmacy · Ozempic shortage
The most common causes a clinician considers. This isn't a diagnosis — it's the differential a provider works through with you.
Obesity / weight management is one of the more common causes of compounded semaglutide and the shortage. A provider can confirm with the right history, exam, or labs — and start treatment the same day when appropriate.
Type 2 diabetes is one of the more common causes of compounded semaglutide and the shortage. A provider can confirm with the right history, exam, or labs — and start treatment the same day when appropriate.
What a clinician usually orders or asks about when someone presents with compounded semaglutide and the shortage.
Discuss compounded semaglutide and the shortage directly with our medical director.
Most requests reviewed within 24 hours; prescriptions sent to your pharmacy.
Plain-language explainer of the most likely underlying cause.
A1c, thyroid, iron, hormones, STI panels, and more.
For existing prescriptions.

Board-Certified · Internal Medicine · Medical Director
All 50 states + DC·Video visit
In-network: Aetna, BCBS, UnitedHealthcare +18 more plans